Ting Deng

机构：Tianjin Medical University · ORCID：0000-0001-5477-7972

发表论文 310 篇 · 总被引 10456 次 · h-index 51

代表论文

• CLDN18.2–targeting antibody–drug conjugate IBI343 in advanced gastric or gastroesophageal junction adenocarcinoma: a phase 1 trial (2025 · Nature Medicine · 被引 39)
• Development and validation of an explainable machine learning model for predicting postoperative pulmonary complications after lung cancer surgery: a machine learning study (2025 · EClinicalMedicine · 被引 23)
• Efficacy and safety of glecirasib in solid tumors with KRAS G12C mutation: A pooled analysis of two phase I/II trials (2025 · 癌症：英文版 · 被引 12)
• Disitamab vedotin (DV) plus toripalimab (Tor) and chemotherapy (C)/trastuzumab (Tra) as first-line (1L) treatment of patients (pts) with HER2-expressing locally advanced or metastatic (la/m) gastric cancer. (2025 · Journal of Clinical Oncology · 被引 9)
• An ICT-based mitochondrial binding enhanced fluorescent probe for measurement of monoamine oxidase A in living cells (2025 · Talanta · 被引 7)
• Effect of Marine‐Derived Scallop Peptide Hydrolysate on Immune Modulation and Gut Microbiota Restoration in Cyclophosphamide‐Induced Immunosuppressed Mice (2025 · Food Science & Nutrition · 被引 7)